linc‐SCRG1 accelerates liver fibrosis by decreasing RNA‐binding protein tristetraprolin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

linc‐SCRG1 accelerates liver fibrosis by decreasing RNA‐binding protein tristetraprolin

Published:2018-09-18 Issue:2 Volume:33 Page:2105-2115
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Wu Jun-Cheng¹,Luo Sheng-Zheng¹,Liu Ting¹,Lu Lun-Gen¹,Xu Ming-Yi¹

Affiliation:

1. Department of GastroenterologyShanghai General HospitalShanghai Jiao Tong University School of MedicineShanghaiChina

Funder

National Natural Science Foundation of China

Major State Basic Research Development Program of China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201800098RR

Reference37 articles.

1. Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies

2. Activation of hepatic stellate cells - a key issue in liver fibrosis

3. Hepatic Stellate Cells and Liver Fibrosis

4. The expression profiling and ontology analysis of noncoding RNAs in peritoneal fibrosis induced by peritoneal dialysis fluid

5. APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging roles of RNA‐binding proteins in fatty liver disease;WIREs RNA;2024-03

2. Long non-coding RNAs as modulators and therapeutic targets in non-alcoholic fatty liver disease (NAFLD);Gastroenterología y Hepatología;2023-10

3. Engineered fibrotic liver-targeted truncated transforming growth factor β receptor type II variant for superior anti-liver fibrosis therapy;Archives of Pharmacal Research;2023-03

4. RNA-binding proteins in metabolic-associated fatty liver disease (MAFLD): From mechanism to therapy;BioScience Trends;2023-02-28

5. miR-182-5p attenuates <italic>Schistosoma japonicum</italic>-induced hepatic fibrosis by targeting tristetraprolin;Acta Biochimica et Biophysica Sinica;2022-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3